Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, University of Bari "Aldo Moro", School of Medicine, Bari, Apulia, Italy.
Infantile Neuropsychiatry, IRCCS - Institute of Neurological Sciences, Bologna, Italy.
Hormones (Athens). 2024 Mar;23(1):15-23. doi: 10.1007/s42000-023-00505-y. Epub 2023 Nov 18.
The neuropeptide oxytocin (OT) is crucial in several conditions, such as lactation, parturition, mother-infant interaction, and psychosocial function. Moreover, OT may be involved in the regulation of eating behaviors.
This review briefly summarizes data concerning the role of OT in eating behaviors. Appropriate keywords and medical subject headings were identified and searched for in PubMed/MEDLINE. References of original articles and reviews were screened, examined, and selected.
Hypothalamic OT-secreting neurons project to different cerebral areas controlling eating behaviors, such as the amygdala, area postrema, nucleus of the solitary tract, and dorsal motor nucleus of the vagus nerve. Intracerebral/ventricular OT administration decreases food intake and body weight in wild and genetically obese rats. OT may alter food intake and the quality of meals, especially carbohydrates and sweets, in humans.
OT may play a role in the pathophysiology of eating disorders with potential therapeutic perspectives. In obese patients and those with certain eating disorders, such as bulimia nervosa or binge/compulsive eating, OT may reduce appetite and caloric consumption. Conversely, OT administered to patients with anorexia nervosa may paradoxically stimulate appetite, possibly by lowering anxiety which usually complicates the management of these patients. Nevertheless, OT administration (e.g., intranasal route) is not always associated with clinical benefit, probably because intranasally administered OT fails to achieve therapeutic intracerebral levels of the hormone.
OT administration could play a therapeutic role in managing eating disorders and disordered eating. However, specific studies are needed to clarify this issue with regard to dose-finding and route and administration time.
神经肽催产素(OT)在许多情况下都很重要,例如哺乳、分娩、母婴互动和社会心理功能。此外,OT 可能参与了进食行为的调节。
本综述简要总结了 OT 在进食行为中的作用的数据。在 PubMed/MEDLINE 中确定并搜索了适当的关键词和医学主题词。筛选、检查和选择了原始文章和综述的参考文献。
下丘脑 OT 分泌神经元投射到控制进食行为的不同脑区,如杏仁核、后极、孤束核和迷走神经背核。脑室内/脑室 OT 给药可减少野生型和遗传性肥胖大鼠的食物摄入量和体重。OT 可能会改变人类的食物摄入量和膳食质量,尤其是碳水化合物和甜食。
OT 可能在进食障碍的病理生理学中发挥作用,具有潜在的治疗前景。在肥胖患者和某些进食障碍患者中,如神经性贪食症或暴食/强迫性进食,OT 可能会降低食欲和热量摄入。相反,OT 给药可能会对神经性厌食症患者产生相反的效果,刺激食欲,可能是通过降低焦虑来实现的,而焦虑通常会使这些患者的治疗复杂化。然而,OT 给药(例如,鼻内途径)并不总是与临床获益相关,可能是因为鼻内给予的 OT 未能达到该激素的治疗性脑内水平。
OT 给药可能在治疗进食障碍和饮食失调方面发挥治疗作用。然而,需要特定的研究来明确剂量、给药途径和时间等方面的问题。